(Q41589138)

4 October 2017

title

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

L. Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

S. Ashe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

W. A. Brady

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

I. Hellström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

K. E. Hellström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

J. A. Ledbetter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

P. McGowan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

P. S. Linsley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335364

15 September 2022

language of work or name

English

0 references

publication date

1 December 1992

1 reference

4 October 2017

24 December 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1335364

15 September 2022

1 reference

4 October 2017

1 reference

4 October 2017

1 reference

4 October 2017

page(s)

1093-1102

1 reference

CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Reversal of in vitro T cell clonal anergy by IL-2 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Toward a genetic analysis of tumor rejection antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Perspectives on the role of MHC antigens in normal and malignant cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Role of the CD28 receptor in T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Transactivation by AP-1 is a molecular target of T cell clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

CTLA-4 is a second receptor for the B cell activation antigen B7

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Costimulation of T-cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Heat-stable antigen is a costimulatory molecule for CD4 T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Immunologic tolerance: collaboration between antigen and lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Acquisition of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Roles of multiple accessory molecules in T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2805%2980059-5

7 January 2021

10.1016/S0092-8674(05)80059-5

Identifiers

DOI

1 reference

4 October 2017

1 reference